InChI=1S/C23H37NO5S/c1- 2- 3- 12- 15- 20(25) 21(30- 18- 19(24) 23(28) 29) 16- 13- 10- 8- 6- 4- 5- 7- 9- 11- 14- 17- 22(26) 27/h4,6- 10,13,16,19- 21,25H,2- 3,5,11- 12,14- 15,17- 18,24H2,1H3,(H,26,27) (H,28,29) /b6- 4- ,9- 7- ,10- 8+,16- 13+/t19- ,20- ,21+/m0/s1 |
JLJNENVYAVKECZ-HRXVJLLUSA-N |
CCCCC[C@H](O)[C@H](SC[C@H](N)C(O)=O)\C=C\C=C\C=C/C\C=C/CCCC(O)=O |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
(5Z,8Z,10E,12E,14R,15S)- 14- {[(2R)- 2- amino- 2- carboxyethyl]sulfanyl}- 15- hydroxyicosa- 5,8,10,12- tetraenoic acid
|
S- [(6S,7R,8E,10E,12Z,15Z)- 19- carboxy- 6- hydroxynonadeca- 8,10,12,15- tetraen- 7- yl]- L- cysteine
|
14,15-Leukotriene E4
|
SUBMITTER
|
14,15-LTE4
|
SUBMITTER
|
15S-hydroxy,14R-(S-cysteinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
LIPID MAPS
|
EXE4
|
SUBMITTER
|
19521974
|
Reaxys Registry Number
|
Reaxys
|
|